Zhisong He
- Urology top 10%
-
- Bladder and Urothelial Cancer Treatments 15
- Urinary and Genital Oncology Studies 7
-
- Cancer Immunotherapy and Biomarkers 5
-
- Renal cell carcinoma treatment 8
- Prostate Cancer Treatment and Research 5
- Ferroptosis and cancer prognosis 3
-
- Multiple and Secondary Primary Cancers 4
-
- Cancer, Lipids, and Metabolism 3
- Journals
- Journal of Clinical Oncology (5 papers)Frontiers in Oncology (2 papers)Patient Preference and Adherence (1 paper)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Zhisong He
30 papers receiving 269 citations
Peers
Comparison fields: 5 of 42
- Urology 52
- Surgery 187
- Oncology 77
- Pulmonary and Respiratory Medicine 86
- Radiology, Nuclear Medicine and Imaging 23
Countries citing papers authored by Zhisong He
This map shows the geographic impact of Zhisong He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhisong He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhisong He more than expected).
Fields of papers citing papers by Zhisong He
This network shows the impact of papers produced by Zhisong He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhisong He. The network helps show where Zhisong He may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhisong He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 18 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 2 | |
| 5 | 2022 | 20 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 1 | |
| 8 | 2020 | 5 | |
| 9 | 2017 | 1 | |
| 10 | 2016 | 15 | |
| 11 | 2014 | 2 | |
| 12 | 2013 | 15 | |
| 13 | 2013 | 53 | |
| 14 | [Urachal carcinoma: experience of a clinical center within 30 years]. | 2013 | 2 |
| 15 | 2012 | 13 | |
| 16 | 2010 | 26 | |
| 17 | [Clinical utility of fluorescence in situ hybridization improves the sensitivity in the diagnosis of upper urinary tract urothelial carcinoma]. | 2010 | 1 |
| 18 | [Diagnose and therapy for urinary tract endometriosis: a report of 22 cases]. | 2010 | 0 |
| 19 | [Changes in clinical features of inpatients with prostate cancer in the past 11 years]. | 2010 | 1 |
| 20 | [Differential transcription of Bcl-2 and Bax through the cell cycle in prostate cancer cell line]. | 2008 | 1 |
About Zhisong He
Zhisong He is a scholar working on Pulmonary and Respiratory Medicine, Urology and Surgery, having authored 34 papers that have together received 274 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (15 papers), Renal cell carcinoma treatment (8 papers), Urinary and Genital Oncology Studies (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Prostate Cancer Treatment and Research (5 papers), Multiple and Secondary Primary Cancers (4 papers), Cancer, Lipids, and Metabolism (3 papers) and Ferroptosis and cancer prognosis (3 papers). The work is most often cited by research in Urology (52 citations), Surgery (187 citations) and Oncology (77 citations). Zhisong He has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Liqun Zhou, Xuesong Li, Dong Fang, Lin Yao, Gengyan Xiong, Xinan Sheng, Jiyan Liu, Yanxia Shi, Benkang Shi and Hong Luo. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, Patient Preference and Adherence, Journal of Endourology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.